Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution

Clinical trial NCT04903730 · COMPLETED

Trial details

NCT number: NCT04903730
Sponsor: Aerami Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2021-05-24
Primary completion: 2022-12-02
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.